These NPs with tumor-targeting abilities were quickly taken up by tumor cells in vivo to inhibit the expression of the gene encoding the vascular endothelial growth factor (VEGF), leading to reduced angiogenesis in tumor tissues. Here, VEGFA is linked to neoplasm.